Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

Part of BASF SE, Ciba Specialty Chemicals Holding, Inc. is a Swiss company that develops and produces chemicals, performance products, functional materials, and related goods.

3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Baker Hughes Oilfield Operations LLC, a subsidiary of Baker Hughes Co., is a company headquartered in Houston, TX. The firm provides oilfield services.

Part of Compagnie Générale des Établissements Michelin SCA, Société de Technologie Michelin is a French company that manufactures automobile tires, tubes and related products.

Rhodia Chimie, part of Solvay SA, is a French company located in Aubervilliers that leases intellectual property and patents.

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

AK ChemTech Co., Ltd., part of AK Holdings, Inc., is a company headquartered in Seoul, the South Korea. The firm manufactures and sells surfactants, industrial cleansing agents, paints and surface treatment products. It was founded in 1982. Aekyung Petrochemical Co., Ltd. acquired AK ChemTech Co., Ltd. from AK Holdings, Inc. on November 01, 2021.

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of important medicines for patients with cancer and other life-threatening conditions. Enzon has a portfolio of four marketed products, ONCASPAR®, DEPOCYT®, ABELCET® and ADAGEN®. The Company's drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform used to create product candidates with benefits such as reduced dosing frequency and less toxicity. Enzon's PEGylation technology was used to develop two of its products, ONCASPAR and ADAGEN, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. Enzon also engages in contract manufacturing for several pharmaceutical companies to broaden the Company's revenue base.

XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.

Provides materials management products and solutions

Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.

Zhonghongxin Investment Holdings (Shenzhen) Co., Ltd., established on 2017-03-22, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Economic Information Consulting(Specific projects will be reported separately);Internet Industry Investment;supply chain management;Investment Advisory,Economic Information Consulting,Business Consulting,Business Management Consulting(None of the above items are restricted);Investment;Cultural Event Planning;marketing planning;Exhibition planning;Corporate Image Planning;account Serive;product design;in the advertising business(laws and regulations,The State Council stipulates that it is necessary to separately handle the approval of advertising business,Licensed to operate);Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);Do business online(No restricted items).(All of the above are related to the law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:

Manufactures pharmaceuticals and diagnostic substances

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.

FPInnovations is a not-for-profit R&D private organization that specializes in the creation of solutions that accelerate the growth of the Canadian forest sector and its affiliated industries to enhances their global competitiveness. Its expertise spans the pulp and paper industry, forest operations, wood products, and bio-sourced products. It focuses on transforming and diversifying the Canadian forest sector and creates solutions along the entire value chain, from forest management to consumer. FPInnovations has a unique industry-government partnership model and acts an innovation catalyst for Canada’s forest sector. It employs more than 400 specialists throughout Canada and has an annual operating budget of $76 million. Its membership totals to 180 industry companies. Its board of directors represents industry members as well as provincial and federal governments.

XP Chemistries AB engages in biotechnology research and experimental development. It operates through the following business areas: Feed, Cosmetics, Life, and Protect. The Feed business area focuses on animal feed supplements with capsaicin. The Cosmetics area markets pharmaceutical products. The Life business area offers capsaicin-based dietary supplements and life sciences. The Protect area manufactures antifouling paints and sprays. The company was founded by Armando Cordova and Samson Afewerki in 2015 and is headquartered in Sundsvall, Sweden.